These Healthcare stocks are trading higher:
-Lixte Biotechnology Holdings Inc (LIXT) stock is trading at $2.20, a gain of $0.85, or 62.22%, on high volume. Lixte Biotech Hlds gets a Sentiment Score of Bullish from InvestorsObserver.
-CNS Pharmaceuticals Inc (CNSP) stock is trading at $1.18, an increase of $0.38, or 47.63%, on high volume. Cns Pharmaceuticals Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $7.00.
-Mainz Biomed BV (MYNZ) stock is trading at $14.28, a rise of $3.89, or 37.73%, on high volume. Mainz Biomed B.V. gets a Sentiment Score of Bearish from InvestorsObserver.
-Castlight Health Inc (CSLT) stock is trading at $2.03, a rise of $0.4, or 24.6%, on high volume. Castlight Health Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $2.28. Castlight Health Inc next reports earnings on January 31.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Annexon Inc (ANNX) stock is trading at $7.18, a decline of $3.83, or 34.81%, on high volume. Annexon Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $38.20.-Hoth Therapeutics Inc (HOTH) stock is trading at $1.03, a decline of $0.27, or 20.76%, on high volume. Hoth Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.00.
-Nutriband Inc (NTRB) stock is trading at $7.36, a decline of $1.63, or 18.19%, on low volume. Nutriband Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $17.00.
-Genprex Inc (GNPX) stock is trading at $2.32, a loss of $0.47, or 16.85%, on average volume. Genprex Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.25.
